SCICLONE PHARMACEUTICALS INC 4

4 · SCICLONE PHARMACEUTICALS INC · Filed Jun 1, 2005

Form 4

Period: 2005-05-29

Director

Transactions

Award
Non-Qualified Stock Option (right to buy)
2005-05-29+30,000→ 30,000 total
Exercise: $5.23Exp: 2014-05-26→ Common Stock (30,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2005-05-29−10,000→ 0 total
Exercise: $3.69Exp: 2008-06-26→ Common Stock (10,000 underlying)
Award
Non-Qualified Stock Option (right to buy)
2005-05-29+10,000→ 10,000 total
Exercise: $3.69Exp: 2008-06-26→ Common Stock (10,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2005-05-29−20,000→ 0 total
Exercise: $3.84Exp: 2012-05-30→ Common Stock (20,000 underlying)
Award
Non-Qualified Stock Option (right to buy)
2005-05-29+20,000→ 20,000 total
Exercise: $3.84Exp: 2012-05-30→ Common Stock (20,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2005-05-29−30,000→ 0 total
Exercise: $5.23Exp: 2014-05-26→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]Amendment of outstanding option to extend the post-termination exercise period resulting in deemed cancellation of option and grant of replacement option. Options are fully vested and exercisable.

Documents

1 file